| Financial Year |
March 31 2023 |
| Monetary Funds |
553,119,978.27 |
| Held-for-trading Financial Assets |
376,261,619.17 |
| Notes Receivable |
-- |
| Accounts Receivable |
294,394,814.56 |
| Advances to Suppliers |
10,021,644.63 |
| Other Receivables |
6,133,752.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
93,157,668.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,007,191.63 |
| Total Current Assets |
1,426,255,240.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
213,680.69 |
| Fixed Assetes |
236,501,928.46 |
| Under-construction Projects |
76,448,843.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
130,710,896.04 |
| R&D expenses |
29,228,104.71 |
| Goodwill |
200,643,602.10 |
| Long-Term Deferred and Prepaid Expenses |
1,044,377.06 |
| Deferred Income Tax Assets |
28,722,393.70 |
| Other Non-Current Assets |
12,637,866.85 |
| Sub-Total of Non-Current Assets |
756,009,863.61 |
| Total Assets |
2,182,265,103.71 |
| Short-Term Loans |
20,010,417.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
58,605,268.35 |
| Accounts Received In Advance |
59,633.03 |
| Employee Compensation Payable |
8,153,881.63 |
| Taxes Payable |
61,041,596.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
53,334,366.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,367,509.16 |
| Other Current Liabilities |
352,472.83 |
| Sub-Total of Current Liabilities |
206,214,309.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,366,027.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
43,810,206.96 |
| Total Liabilities |
250,024,516.91 |
| Paid-In Capital(Or Share Stock) |
236,387,500.00 |
| Capital Surplus |
1,109,159,229.71 |
| Surplus Reserve |
68,005,211.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
492,160,962.51 |
| Minority Stockholder's Interest |
26,229,267.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,906,011,319.52 |
| Owner's Equity（Stockholder's Equity） |
1,932,240,586.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,182,265,103.71 |
